Imprecise medicine: The limitations of sepsis-3

Critical Care Medicine

Volumn 44, Issue 5, 2016, Pages 857-858

  Deutschman, Clifford S ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONSENSUS; CRITICALLY ILL PATIENT; DIFFERENTIAL DIAGNOSIS; EDITORIAL; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; INTENSIVE CARE; LABORATORY TEST; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; MULTIPLE ORGAN FAILURE; NOMENCLATURE; PATHOPHYSIOLOGY;

BIOLOGICAL MARKER;

BIOMARKERS; HUMANS; MULTIPLE ORGAN FAILURE; SEPSIS; TERMINOLOGY AS TOPIC;

EID: 84963876745     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000001834     Document Type: Editorial

References (7)

1. Olofsson PS, Rosas-Ballina M, Levine YA, Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev 2012 248 188 204
2. Singer M, Deutschman CS, Seymour CS, The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016 31 801 810
3. Buchman TG, Cabin DE, Porter JM, Bulkley GB, Changes in hepatic gene expression after shock/resuscitation. Surgery 1989 106 283 90. discussion 290-291
4. De Campos T, Deree J, Coimbra R, From acute pancreatitis to end-organ injury: mechanisms of acute lung injury. Surg Infect (Larchmt) 2007 8 107 120
5. Bown MJ, Nicholson ML, Bell PR, Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001 22 485 495
6. Deutschman CS, Raj NR, McGuire EO, Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med 2013 41 e368 e375
7. Hotchkiss RS, Monneret G, Payen D, Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat Rev Immunol 2013 13 862 874